These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9124847)

  • 1. Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.
    Slayden RA; Lee RE; Armour JW; Cooper AM; Orme IM; Brennan PJ; Besra GS
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2813-9. PubMed ID: 9124847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity.
    Douglas JD; Senior SJ; Morehouse C; Phetsukiri B; Campbell IB; Besra GS; Minnikin DE
    Microbiology (Reading); 2002 Oct; 148(Pt 10):3101-3109. PubMed ID: 12368443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
    Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
    J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB).
    Sridharan S; Wang L; Brown AK; Dover LG; Kremer L; Besra GS; Sacchettini JC
    J Mol Biol; 2007 Feb; 366(2):469-80. PubMed ID: 17174327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.
    Kremer L; Douglas JD; Baulard AR; Morehouse C; Guy MR; Alland D; Dover LG; Lakey JH; Jacobs WR; Brennan PJ; Minnikin DE; Besra GS
    J Biol Chem; 2000 Jun; 275(22):16857-64. PubMed ID: 10747933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
    Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3685-8. PubMed ID: 14552758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.
    Phetsuksiri B; Baulard AR; Cooper AM; Minnikin DE; Douglas JD; Besra GS; Brennan PJ
    Antimicrob Agents Chemother; 1999 May; 43(5):1042-51. PubMed ID: 10223912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.
    Slayden RA; Barry CE
    Tuberculosis (Edinb); 2002; 82(4-5):149-60. PubMed ID: 12464486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12.
    Tsay JT; Rock CO; Jackowski S
    J Bacteriol; 1992 Jan; 174(2):508-13. PubMed ID: 1729241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria.
    Madacki J; Laval F; Grzegorzewicz A; Lemassu A; Záhorszká M; Arand M; McNeil M; Daffé M; Jackson M; Lanéelle MA; Korduláková J
    J Biol Chem; 2018 Apr; 293(14):5172-5184. PubMed ID: 29472294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis.
    Parrish NM; Kuhajda FP; Heine HS; Bishai WR; Dick JD
    J Antimicrob Chemother; 1999 Feb; 43(2):219-26. PubMed ID: 11252327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria.
    Kurth DG; Gago GM; de la Iglesia A; Bazet Lyonnet B; Lin TW; Morbidoni HR; Tsai SC; Gramajo H
    Microbiology (Reading); 2009 Aug; 155(Pt 8):2664-2675. PubMed ID: 19423629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Molecular Genetics of Mycolic Acid Biosynthesis.
    PaweŁczyk J; Kremer L
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0003-2013. PubMed ID: 26104214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development.
    Bhatt A; Molle V; Besra GS; Jacobs WR; Kremer L
    Mol Microbiol; 2007 Jun; 64(6):1442-54. PubMed ID: 17555433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling the Biosynthetic Pathway for Short Mycolic Acids in Nontuberculous Mycobacteria: Mycobacterium smegmatis MSMEG_4301 and Its Ortholog Mycobacterium abscessus MAB_1915 Are Essential for the Synthesis of α'-Mycolic Acids.
    Di Capua CB; Belardinelli JM; Carignano HA; Buchieri MV; Suarez CA; Morbidoni HR
    Microbiol Spectr; 2022 Aug; 10(4):e0128822. PubMed ID: 35862962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiolactomycin resistance in Escherichia coli is associated with the multidrug resistance efflux pump encoded by emrAB.
    Furukawa H; Tsay JT; Jackowski S; Takamura Y; Rock CO
    J Bacteriol; 1993 Jun; 175(12):3723-9. PubMed ID: 8509326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.
    Veyron-Churlet R; Molle V; Taylor RC; Brown AK; Besra GS; Zanella-Cléon I; Fütterer K; Kremer L
    J Biol Chem; 2009 Mar; 284(10):6414-24. PubMed ID: 19074144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
    Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.